Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte Implantation

Category: Arthroscopy Introduction/Purpose: Osteochondral lesions of the talus (OLT) are frequent occurrences when patients sustain both traumatic and atraumatic ankle injuries with a report rate of up to 70% OLT in patients who sustain an ankle sprain or fracture. Surgical treatment options for OLT...

Full description

Bibliographic Details
Main Authors: Christopher E. Gross MD, Brandon J. Erickson MD, Yale A. Fillingham MD, Michael D. Hellman MD, Samuel B. Adams MD, Selene G. Parekh MD, MBA
Format: Article
Language:English
Published: SAGE Publishing 2016-08-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011416S00218
_version_ 1818619619137552384
author Christopher E. Gross MD
Brandon J. Erickson MD
Yale A. Fillingham MD
Michael D. Hellman MD
Samuel B. Adams MD
Selene G. Parekh MD, MBA
author_facet Christopher E. Gross MD
Brandon J. Erickson MD
Yale A. Fillingham MD
Michael D. Hellman MD
Samuel B. Adams MD
Selene G. Parekh MD, MBA
author_sort Christopher E. Gross MD
collection DOAJ
description Category: Arthroscopy Introduction/Purpose: Osteochondral lesions of the talus (OLT) are frequent occurrences when patients sustain both traumatic and atraumatic ankle injuries with a report rate of up to 70% OLT in patients who sustain an ankle sprain or fracture. Surgical treatment options for OLT is either reparative or replacement and are dictated by characteristics of the lesion, including size and presence or absence of cysts. Periosteal-autologous chondrocyte implantation (P-ACI) or MACI (matrix-induced autologous chondrocyte implantation) is useful for lesions with or without cysts under 2.5cm2. We hypothesize that MACI will have the lowest reoperation rate and highest patient satisfaction rate in treating OLT. Methods: A systematic review was registered with PROSPERO and performed with PRISMA guidelines using three publicly available free databases. Therapeutic clinical outcome investigations reporting OLT outcomes with levels of evidence I-IV were eligible for inclusion. All study, subject, and surgical technique demographics were analyzed and compared between continents and countries. Statistics were calculated using Student’s t-tests, one-way ANOVA, chi-squared, and two-proportion Z-tests. Results: Nineteen articles met our inclusion criteria, which resulted in a total of 343 patients. Six studies pertained to arthroscopic MACI, 8 to open MACI, and 5 studies to open PACI. All studies were Level IV evidence. Due to study quality, imprecise and sparse data, and potential for reporting bias, the quality of evidence is low. In comparison of open and arthroscopic MACI, we found both advantages favoring open MACI (AOFAS and MOCART score). However, open MACI had higher complication rates versus arthroscopic (18.18% vs 0.78%, p = 0.002). In addition, the rate of impingement was noted to be significantly higher for the open technique of MACI with a rate of 10.61% as opposed to 0.78% for the arthroscopic technique (p = 0.01). Conclusion: No procedure demonstrates superiority or inferiority between the combination of open or arthroscopic MACI and PACI in the management of OLT less than 2.5 cm2. Ultimately well-designed randomized trials are needed to address the limitation of the available literature and further our understanding of the optimal treatment options.
first_indexed 2024-12-16T17:40:22Z
format Article
id doaj.art-5f897b5a2378477bac2bdbc4e26df332
institution Directory Open Access Journal
issn 2473-0114
language English
last_indexed 2024-12-16T17:40:22Z
publishDate 2016-08-01
publisher SAGE Publishing
record_format Article
series Foot & Ankle Orthopaedics
spelling doaj.art-5f897b5a2378477bac2bdbc4e26df3322022-12-21T22:22:37ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142016-08-01110.1177/2473011416S00218Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte ImplantationChristopher E. Gross MDBrandon J. Erickson MDYale A. Fillingham MDMichael D. Hellman MDSamuel B. Adams MDSelene G. Parekh MD, MBACategory: Arthroscopy Introduction/Purpose: Osteochondral lesions of the talus (OLT) are frequent occurrences when patients sustain both traumatic and atraumatic ankle injuries with a report rate of up to 70% OLT in patients who sustain an ankle sprain or fracture. Surgical treatment options for OLT is either reparative or replacement and are dictated by characteristics of the lesion, including size and presence or absence of cysts. Periosteal-autologous chondrocyte implantation (P-ACI) or MACI (matrix-induced autologous chondrocyte implantation) is useful for lesions with or without cysts under 2.5cm2. We hypothesize that MACI will have the lowest reoperation rate and highest patient satisfaction rate in treating OLT. Methods: A systematic review was registered with PROSPERO and performed with PRISMA guidelines using three publicly available free databases. Therapeutic clinical outcome investigations reporting OLT outcomes with levels of evidence I-IV were eligible for inclusion. All study, subject, and surgical technique demographics were analyzed and compared between continents and countries. Statistics were calculated using Student’s t-tests, one-way ANOVA, chi-squared, and two-proportion Z-tests. Results: Nineteen articles met our inclusion criteria, which resulted in a total of 343 patients. Six studies pertained to arthroscopic MACI, 8 to open MACI, and 5 studies to open PACI. All studies were Level IV evidence. Due to study quality, imprecise and sparse data, and potential for reporting bias, the quality of evidence is low. In comparison of open and arthroscopic MACI, we found both advantages favoring open MACI (AOFAS and MOCART score). However, open MACI had higher complication rates versus arthroscopic (18.18% vs 0.78%, p = 0.002). In addition, the rate of impingement was noted to be significantly higher for the open technique of MACI with a rate of 10.61% as opposed to 0.78% for the arthroscopic technique (p = 0.01). Conclusion: No procedure demonstrates superiority or inferiority between the combination of open or arthroscopic MACI and PACI in the management of OLT less than 2.5 cm2. Ultimately well-designed randomized trials are needed to address the limitation of the available literature and further our understanding of the optimal treatment options.https://doi.org/10.1177/2473011416S00218
spellingShingle Christopher E. Gross MD
Brandon J. Erickson MD
Yale A. Fillingham MD
Michael D. Hellman MD
Samuel B. Adams MD
Selene G. Parekh MD, MBA
Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte Implantation
Foot & Ankle Orthopaedics
title Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte Implantation
title_full Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte Implantation
title_fullStr Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte Implantation
title_full_unstemmed Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte Implantation
title_short Management of Osteochondral Lesions of the Talus Using Autologous Chondrocyte Implantation
title_sort management of osteochondral lesions of the talus using autologous chondrocyte implantation
url https://doi.org/10.1177/2473011416S00218
work_keys_str_mv AT christopheregrossmd managementofosteochondrallesionsofthetalususingautologouschondrocyteimplantation
AT brandonjericksonmd managementofosteochondrallesionsofthetalususingautologouschondrocyteimplantation
AT yaleafillinghammd managementofosteochondrallesionsofthetalususingautologouschondrocyteimplantation
AT michaeldhellmanmd managementofosteochondrallesionsofthetalususingautologouschondrocyteimplantation
AT samuelbadamsmd managementofosteochondrallesionsofthetalususingautologouschondrocyteimplantation
AT selenegparekhmdmba managementofosteochondrallesionsofthetalususingautologouschondrocyteimplantation